New Zealand raises concerns with Upjohn/Mylan tie-up

Charles McConnell

27 March 2020

New Zealand raises concerns with Upjohn/Mylan tie-up

Credit: Shutterstock/ricochet64

The proposed merger of Pfizer’s off-patent branded and generic established medicines business with Mylan raises competition concerns over the supply of several molecules, New Zealand’s competition watchdog has said.